Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

553.66
Delayed Data
As of Jul 31
 +6.56 / +1.20%
Today’s Change
310.69
Today|||52-Week Range
569.91
+34.96%
Year-to-Date

Today’s Trading

Previous close547.10
Today’s open551.29
Day’s range547.85 - 558.50
Volume501,079
Average volume (3 months)723,051
Market cap$57.1B
Dividend yield--
Data as of 07/31/2015

Growth & Valuation

Earnings growth (last year)-19.42%
Earnings growth (this year)+11.77%
Earnings growth (next 5 years)+25.29%
Revenue growth (last year)+33.96%
P/E ratio177.4
Price/Sales16.50
Price/Book22.26

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+1.97+1.57%
QQuintiles Transnatio...-2.03-2.58%
ISISIsis Pharmaceuticals...+1.76+3.31%
ICLRICON PLC-0.06-0.07%
Data as of 07/31/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)$2.78
Annual revenue (last year)$2.8B
Annual profit (last year)$348.1M
Net profit margin12.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts